NASDAQ:ATAI • US04650F1012
The current stock price of ATAI is 4.195 USD. Today ATAI is up by 7.84%. In the past month the price increased by 3.18%. In the past year, price increased by 162.84%.
ChartMill assigns a technical rating of 5 / 10 to ATAI. When comparing the yearly performance of all stocks, ATAI is one of the better performing stocks in the market, outperforming 95.35% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to ATAI. While ATAI has a great health rating, there are worries on its profitability.
On November 12, 2025 ATAI reported an EPS of -0.28 and a revenue of 749.00K. The company missed EPS expectations (-131.54% surprise) and beat revenue expectations (1221.66% surprise).
19 analysts have analysed ATAI and the average price target is 12.7 USD. This implies a price increase of 202.83% is expected in the next year compared to the current price of 4.195.
For the next year, analysts expect an EPS growth of 31.19% and a revenue growth 475.15% for ATAI
Over the last trailing twelve months ATAI reported a non-GAAP Earnings per Share(EPS) of -0.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -62.24% | ||
| ROE | -93.44% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 28.73 | 951.275B | ||
| JNJ | JOHNSON & JOHNSON | 20.94 | 584.618B | ||
| MRK | MERCK & CO. INC. | 22.91 | 289.542B | ||
| PFE | PFIZER INC | 9.13 | 152.449B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.58 | 123.471B | ||
| ZTS | ZOETIS INC | 17.29 | 51.652B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.94 | 26.443B | ||
| VTRS | VIATRIS INC | 5.74 | 16.373B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.1 | 11.902B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.414B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.72B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.704B | ||
| AMRX | AMNEAL PHARMACEUTICALS INC | 13.85 | 4.169B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
The company is headquartered in New York City, New York and currently employs 54 full-time employees. The company went IPO on 2021-06-18.
IPO: 2021-06-18
ATAIBECKLEY INC
c/o atai Life Sciences US, Inc., c/o Industrious NYC, 250 West 34th Street
New York City NEW YORK 100022 US
CEO: Florian Brand
Employees: 54
Phone: 13026587581
The company is headquartered in New York City, New York and currently employs 54 full-time employees. The company went IPO on 2021-06-18.
The current stock price of ATAI is 4.195 USD. The price increased by 7.84% in the last trading session.
ATAI does not pay a dividend.
ATAI has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ATAI.
ATAIBECKLEY INC (ATAI) currently has 54 employees.
The outstanding short interest for ATAIBECKLEY INC (ATAI) is 4.28% of its float.